tgr-1202
Showing 1 - 7 of 7
Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Polycythemia Vera
- TGR-1202
- ruxolitinib
-
Phoenix, Arizona
- +4 more
Jun 20, 2022
Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in United States (TGR-1202, TGR-1202 + Ublituximab)
Terminated
- Chronic Lymphocytic Leukemia
- Non Hodgkin Lymphoma
- TGR-1202
- TGR-1202 + Ublituximab
-
Huntsville, Alabama
- +16 more
Jul 20, 2022
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (TGR-1202, Ibrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Mantle Cell Lymphoma
- TGR-1202
- Ibrutinib
-
Monterey, California
- +4 more
Aug 29, 2022
Follicular Lymphoma Trial in New York (TGR-1202)
Terminated
- Follicular Lymphoma
- TGR-1202
-
New York, New YorkColumbia University Medical Center
Jun 28, 2021
Hodgkin Disease, Lymphoma, Non-hodgkin Trial in New York (Carfilzomib, TGR-1202)
Terminated
- Hodgkin Disease
- Lymphoma, Non-hodgkin
- Carfilzomib
- TGR-1202
-
New York, New YorkColumbia University Irving Medical Center - Center for Lymphoid
Jun 28, 2021
Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Obinutuzumab
- +3 more
-
Huntsville, Alabama
- +153 more
Aug 19, 2022
Pancreatic Cancer, Colorectal Cancer, Rectal Cancer Trial in Nashville (TGR-1202, nab-paclitaxel + gemcitabine, Oxaliplatin +
Completed
- Pancreatic Cancer
- +5 more
- TGR-1202
- +3 more
-
Nashville, TennesseeTG Therapeutics Trial Site
Oct 1, 2019